AnaptysBio, Inc. Announces Agreement with Roche to Develop Novel Antibodies

SAN DIEGO--(BUSINESS WIRE)--AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced it has signed an agreement with Roche for the development of novel antibody therapeutics.

MORE ON THIS TOPIC